[{"Assets_0_Q2_USD":4441600000.0,"CommonStockSharesOutstanding_0_Q2_shares":145221009.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":84500000.0,"NetIncomeLoss_2_Q2_USD":34600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":145058230.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":143285870.0,"StockholdersEquity_0_Q2_USD":1563000000.0,"EarningsPerShareBasic_1_Q2_USD":0.34,"EarningsPerShareBasic_2_Q2_USD":0.24,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20181231","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20190205"}]